Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Interleukin-17 | 4 | 2013 | 71 | 0.920 |
Why?
|
| Interleukin-17 | 5 | 2013 | 908 | 0.650 |
Why?
|
| Melanosis | 1 | 2014 | 85 | 0.460 |
Why?
|
| Waldenstrom Macroglobulinemia | 8 | 2009 | 1060 | 0.440 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1360 | 0.420 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 938 | 0.420 |
Why?
|
| Mouth | 1 | 2014 | 378 | 0.410 |
Why?
|
| Skin Diseases | 1 | 2019 | 1073 | 0.370 |
Why?
|
| Skin | 2 | 2019 | 4393 | 0.280 |
Why?
|
| Signal Transduction | 5 | 2013 | 23512 | 0.260 |
Why?
|
| Inflammation | 3 | 2020 | 10751 | 0.240 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 10256 | 0.240 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1858 | 0.230 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2755 | 0.230 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2901 | 0.220 |
Why?
|
| Candidiasis, Oral | 2 | 2010 | 59 | 0.180 |
Why?
|
| Fibroblasts | 1 | 2010 | 4160 | 0.170 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5751 | 0.170 |
Why?
|
| ras Proteins | 3 | 2013 | 1065 | 0.160 |
Why?
|
| Autoimmunity | 2 | 2020 | 1374 | 0.150 |
Why?
|
| Skin Diseases, Viral | 1 | 2016 | 21 | 0.140 |
Why?
|
| Chickenpox Vaccine | 1 | 2016 | 79 | 0.140 |
Why?
|
| Melanoma | 1 | 2015 | 5547 | 0.140 |
Why?
|
| Hand Dermatoses | 1 | 2016 | 61 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9664 | 0.130 |
Why?
|
| Herpesvirus 3, Human | 1 | 2016 | 208 | 0.130 |
Why?
|
| Leg Ulcer | 1 | 2015 | 69 | 0.130 |
Why?
|
| Plasma Cells | 2 | 2009 | 596 | 0.120 |
Why?
|
| Cyclosporine | 1 | 2017 | 785 | 0.120 |
Why?
|
| Herpes Zoster | 1 | 2016 | 264 | 0.120 |
Why?
|
| Protein Binding | 3 | 2013 | 9408 | 0.120 |
Why?
|
| Dermatomyositis | 1 | 2016 | 225 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 262 | 0.120 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 287 | 0.120 |
Why?
|
| Complement Factor D | 1 | 2013 | 67 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4403 | 0.110 |
Why?
|
| Cell Line | 4 | 2013 | 16004 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2015 | 334 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 646 | 0.110 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 463 | 0.100 |
Why?
|
| Exanthema | 1 | 2016 | 506 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 553 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 553 | 0.090 |
Why?
|
| Teaching Rounds | 1 | 2014 | 266 | 0.090 |
Why?
|
| Genetic Linkage | 2 | 2007 | 2409 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2013 | 962 | 0.090 |
Why?
|
| Oropharynx | 1 | 2010 | 127 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 626 | 0.090 |
Why?
|
| Mast Cells | 2 | 2008 | 1555 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 1143 | 0.090 |
Why?
|
| Tunicamycin | 1 | 2008 | 112 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 2009 | 378 | 0.080 |
Why?
|
| Animals | 12 | 2020 | 169600 | 0.070 |
Why?
|
| Farnesyltranstransferase | 1 | 2007 | 76 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2010 | 19270 | 0.070 |
Why?
|
| Diacylglycerol Kinase | 1 | 2006 | 47 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9300 | 0.070 |
Why?
|
| Hepatitis C Antibodies | 1 | 2007 | 145 | 0.070 |
Why?
|
| Clonal Anergy | 1 | 2006 | 169 | 0.070 |
Why?
|
| Antigens, CD20 | 1 | 2007 | 200 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2007 | 4028 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2008 | 2693 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7400 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 2042 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1731 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2010 | 5149 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2010 | 5974 | 0.060 |
Why?
|
| Th1 Cells | 2 | 2007 | 1063 | 0.060 |
Why?
|
| Antibodies, Neoplasm | 1 | 2006 | 286 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4121 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 987 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2007 | 436 | 0.060 |
Why?
|
| Mastocytosis | 1 | 2006 | 159 | 0.060 |
Why?
|
| Mice | 8 | 2013 | 81766 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 768 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1155 | 0.060 |
Why?
|
| Receptors, IgG | 1 | 2007 | 583 | 0.060 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 296 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 13042 | 0.050 |
Why?
|
| Penetrance | 1 | 2004 | 384 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 1142 | 0.050 |
Why?
|
| Biopsy | 1 | 2014 | 6771 | 0.050 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 339 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 570 | 0.050 |
Why?
|
| Transfection | 1 | 2010 | 5882 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2008 | 1917 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 1779 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 1368 | 0.050 |
Why?
|
| Humans | 23 | 2020 | 752741 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 1834 | 0.050 |
Why?
|
| Binding Sites | 1 | 2010 | 6118 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12165 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14596 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4733 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2004 | 369 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2007 | 1904 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2227 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 5006 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 18174 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4062 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 3572 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2007 | 1381 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2007 | 1389 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 2387 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1280 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 4716 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2491 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2007 | 2908 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13778 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2006 | 2253 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1572 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 2002 | 0.040 |
Why?
|
| Models, Biological | 1 | 2013 | 9569 | 0.040 |
Why?
|
| Buttocks | 1 | 2016 | 114 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2007 | 1597 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 3766 | 0.030 |
Why?
|
| Apoptosis | 2 | 2008 | 9657 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13678 | 0.030 |
Why?
|
| Virus Activation | 1 | 2016 | 319 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 2555 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 10152 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2009 | 21904 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2016 | 414 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1642 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2010 | 39 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 2010 | 98 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2010 | 61 | 0.020 |
Why?
|
| Leg | 1 | 2015 | 1123 | 0.020 |
Why?
|
| Methotrexate | 1 | 2016 | 1729 | 0.020 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 9743 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2009 | 64 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11553 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17635 | 0.020 |
Why?
|
| Female | 8 | 2017 | 385090 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2007 | 73 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2007 | 104 | 0.020 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2007 | 82 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 146 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2007 | 150 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6493 | 0.020 |
Why?
|
| Gene Expression | 2 | 2009 | 7771 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1012 | 0.020 |
Why?
|
| Adult | 4 | 2014 | 216658 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 29981 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 1675 | 0.020 |
Why?
|
| Protein Folding | 1 | 2008 | 840 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 35447 | 0.020 |
Why?
|
| Methionine | 1 | 2007 | 591 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 621 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9348 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2007 | 8414 | 0.010 |
Why?
|
| Interleukins | 1 | 2009 | 794 | 0.010 |
Why?
|
| Length of Stay | 1 | 2017 | 6355 | 0.010 |
Why?
|
| Quinolones | 1 | 2007 | 369 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 697 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 328 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2017 | 64017 | 0.010 |
Why?
|
| Male | 8 | 2017 | 354311 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 207 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3837 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2888 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11395 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2006 | 1875 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2007 | 1091 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2006 | 1722 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2495 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 58361 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2008 | 1402 | 0.010 |
Why?
|
| Middle Aged | 6 | 2016 | 216054 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13364 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9223 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2927 | 0.010 |
Why?
|
| Piperidines | 1 | 2007 | 1630 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3220 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3674 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4806 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 3731 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 5552 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4327 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40195 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2841 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 4575 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 41390 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10508 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9431 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12970 | 0.010 |
Why?
|
| Aged | 3 | 2009 | 165629 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10469 | 0.010 |
Why?
|
| Child | 1 | 2017 | 78594 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 24248 | 0.000 |
Why?
|
| Prognosis | 1 | 2008 | 29264 | 0.000 |
Why?
|
| Phenotype | 1 | 2004 | 16484 | 0.000 |
Why?
|
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_